These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 19733595)

  • 1. Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses?
    Blankson JN
    Antiviral Res; 2010 Jan; 85(1):295-302. PubMed ID: 19733595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.
    Julg B; Pereyra F; Buzón MJ; Piechocka-Trocha A; Clark MJ; Baker BM; Lian J; Miura T; Martinez-Picado J; Addo MM; Walker BD
    Clin Infect Dis; 2010 Jul; 51(2):233-8. PubMed ID: 20550452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher SLPI expression, lower immune activation, and increased frequency of immune cells in a cohort of Colombian HIV-1 controllers.
    Taborda NA; Cataño JC; Delgado JC; Rugeles MT; Montoya CJ
    J Acquir Immune Defic Syndr; 2012 May; 60(1):12-9. PubMed ID: 22240462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice.
    Salgado M; Swanson MD; Pohlmeyer CW; Buckheit RW; Wu J; Archin NM; Williams TM; Margolis DM; Siliciano RF; Garcia JV; Blankson JN
    J Virol; 2014 Mar; 88(6):3340-52. PubMed ID: 24390323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of the capacity of elite suppressor CD4+ and CD8+ T cells to inhibit HIV-1 replication in monocyte-derived macrophages.
    Walker-Sperling VE; Buckheit RW; Blankson JN
    J Virol; 2014 Sep; 88(17):9789-98. PubMed ID: 24942573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Innate Immunity in Natural Elite Controllers of HIV-1 Infection.
    Shi Y; Su J; Chen R; Wei W; Yuan Z; Chen X; Wang X; Liang H; Ye L; Jiang J
    Front Immunol; 2022; 13():780922. PubMed ID: 35211115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity.
    Alsahafi N; Ding S; Richard J; Markle T; Brassard N; Walker B; Lewis GK; Kaufmann DE; Brockman MA; Finzi A
    J Virol; 2015 Dec; 90(6):2993-3002. PubMed ID: 26719277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers.
    Gonzalo-Gil E; Ikediobi U; Sutton RE
    Yale J Biol Med; 2017 Jun; 90(2):245-259. PubMed ID: 28656011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profile of host restriction factors in HIV-1 elite controllers.
    Abdel-Mohsen M; Raposo RA; Deng X; Li M; Liegler T; Sinclair E; Salama MS; Ghanem Hel-D; Hoh R; Wong JK; David M; Nixon DF; Deeks SG; Pillai SK
    Retrovirology; 2013 Oct; 10():106. PubMed ID: 24131498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.
    Vigneault F; Woods M; Buzon MJ; Li C; Pereyra F; Crosby SD; Rychert J; Church G; Martinez-Picado J; Rosenberg ES; Telenti A; Yu XG; Lichterfeld M
    J Virol; 2011 Mar; 85(6):3015-9. PubMed ID: 21177805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure.
    Casado C; Galvez C; Pernas M; Tarancon-Diez L; Rodriguez C; Sanchez-Merino V; Vera M; Olivares I; De Pablo-Bernal R; Merino-Mansilla A; Del Romero J; Lorenzo-Redondo R; Ruiz-Mateos E; Salgado M; Martinez-Picado J; Lopez-Galindez C
    Sci Rep; 2020 Feb; 10(1):1902. PubMed ID: 32024974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs.
    Buckheit RW; Allen TG; Alme A; Salgado M; O'Connell KA; Huculak S; Falade-Nwulia O; Williams TM; Gallant JE; Siliciano RF; Blankson JN
    Nat Commun; 2012 Mar; 3():716. PubMed ID: 22395607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole Exome Sequencing of HIV-1 long-term non-progressors identifies rare variants in genes encoding innate immune sensors and signaling molecules.
    Nissen SK; Christiansen M; Helleberg M; Kjær K; Jørgensen SE; Gerstoft J; Katzenstein TL; Benfield T; Kronborg G; Larsen CS; Laursen A; Pedersen G; Jakobsen MR; Tolstrup M; Mogensen TH
    Sci Rep; 2018 Oct; 8(1):15253. PubMed ID: 30323326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication
    Jacobs ES; Keating SM; Abdel-Mohsen M; Gibb SL; Heitman JW; Inglis HC; Martin JN; Zhang J; Kaidarova Z; Deng X; Wu S; Anastos K; Crystal H; Villacres MC; Young M; Greenblatt RM; Landay AL; Gange SJ; Deeks SG; Golub ET; Pillai SK; Norris PJ
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
    Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
    J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles.
    Côrtes FH; Passaes CP; Bello G; Teixeira SL; Vorsatz C; Babic D; Sharkey M; Grinsztejn B; Veloso V; Stevenson M; Morgado MG
    J Acquir Immune Defic Syndr; 2015 Apr; 68(4):377-385. PubMed ID: 25564106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the elite: mechanisms of control in HIV-1 infection.
    O'Connell KA; Bailey JR; Blankson JN
    Trends Pharmacol Sci; 2009 Dec; 30(12):631-7. PubMed ID: 19837464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21.
    Chen H; Li C; Huang J; Cung T; Seiss K; Beamon J; Carrington MF; Porter LC; Burke PS; Yang Y; Ryan BJ; Liu R; Weiss RH; Pereyra F; Cress WD; Brass AL; Rosenberg ES; Walker BD; Yu XG; Lichterfeld M
    J Clin Invest; 2011 Apr; 121(4):1549-60. PubMed ID: 21403397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of viral loads between HIV-1-infected elite suppressors and individuals who receive suppressive highly active antiretroviral therapy.
    Dinoso JB; Kim SY; Siliciano RF; Blankson JN
    Clin Infect Dis; 2008 Jul; 47(1):102-4. PubMed ID: 18494606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Responses in Controllers of HIV Infection.
    Kwaa AK; Blankson JN
    Annu Rev Immunol; 2024 Jun; 42(1):21-33. PubMed ID: 37827174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.